The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents

Cardiology

Volumn 108, Issue 1, 2007, Pages 18-27

  Lin, Congrong ^a   Ke, Xiaogang ^a   Cvetanovic, Ivana ^a   Ranade, Vasant ^a   Somberg, John ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti arrhythmic drugs; Extracellular potassium; HERG channel

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; DELAYED RECTIFIER POTASSIUM CHANNEL; DOFETILIDE; POTASSIUM CHANNEL HERG; POTASSIUM ION; QUINIDINE; SOTALOL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; GENE EXPRESSION; HEART ELECTROPHYSIOLOGY; IC 50; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PRIORITY JOURNAL; ROOM TEMPERATURE; VOLTAGE CLAMP; XENOPUS;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; EXTRACELLULAR MATRIX; FEMALE; HYPERKALEMIA; IMIDAZOLIDINES; OOCYTES; PHENETHYLAMINES; PIPERAZINES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROBABILITY; SENSITIVITY AND SPECIFICITY; SOTALOL; SULFONAMIDES; XENOPUS LAEVIS;

EID: 34347340591     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095596     Document Type: Article

References (29)

1. Acker CG, Johnson JP, Palevsky PM, Greenberg A: Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-924.
2. Paice B, Gray JM, McBride D, Donnelly T, Lawson DH: Hyperkalaemia in patients in hospital. Br Med J 1983;286:1189-1192.
3. Moore ML, Bailey RR: Hyperkalaemia in patients in hospital. N Z Med J 1989;102:557-558.
4. Shemer J, Modan M, Ezra D, Cabili S: Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci 1983;19:659-561.
5. Gettes LS, Hill JL, Saito T, Kagiyama Y: Factors related to vulnerability to arrhythmias in acute myocardial infarction. Am Heart J 1982;103:667-672.
6. Wilde AA, Escande D, Schumacher CA, Thuringer D, Mestre M, Fiolet JW, Janse MJ: Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. Circ Res 1990;67:835-843
7. Watanabe I, Johnson TA, Buchanan J, Engle CL, Gettes LS: Effect of graded coronary flow reduction on ionic, electrical, and mechanical indexes of ischemia in the pig. Circulation 1987;76:1127-1134.
8. Pelleg A, Mitamura H, Price R, Kaplinsky E, Menduke H, Dreifus LS, Michelson EL: Extracellular potassium ion dynamics and ventricular arrhythmias in the canine heart. J Am Coll Cardiol 1989;13:941-950.
9. Johnson TA, Engle CL, Boyd LM, Koch GG, Gwinn M, Gettes LS: Magnitude and time course of extracellular potassium inhomogeneities during acute ischemia in pigs. Effect of verapamil. Circulation 1991;83:622-634.
10. Bekheit SS, Restivo M, Boutjdir M, Henkin R, Gooyandeh K, Assadi M, Khatib S, Gough WB, el-Sherif N: Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: a potential new approach to the management of ischemia-induced malignant ventricular arrhythmias. Am Heart J 1990;119:1025-1033.
11. Hicks MN, Cobbe SM: Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol. Cardiovasc Res 1990;24:404-410.
12. Hicks MN, Cobbe SM: Effect of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischaemia in the arterially perfused interventricular septum of rabbit. Cardiovasc Res 1991;25:407-413.
13. Hohnloser SH: Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Am J Cardiol 1997;80:82G-89G.
14. Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-1022.
15. Cobbbe SM, Manley BS: Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol. Cardiovasc Res 1985;19:69-75.
16. Hafner D, Berger F, Borchard U, Kullmann A, Scherlitz A: Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects. Arzneimittelforschung 1988;38:231-236.
17. Marschang H, Beyer T, Karolyi L, Kubler W, Brachmann J: Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle. Cardiovasc Drugs Ther 1998;12:573-583.
18. Baskin EP, Lynch JJ Jr: Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499. J Cardiovasc Pharmacol 1994;24:199-208.
19. Yang T, Tande PM, Lathrop DA, Refsum H: Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle. Cardiovasc Drugs Ther 1992;6:429-436.
20. Gjini V, Korth M, Schreieck J, Weyerbrock S, Schomig A, Schmitt C: Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies. J Cardiovasc Pharmacol 1996;28:314-320.
21. Kr potassium channel. Cell 1995;81:299-307.
22. Trudeau MC, Warmke JW, Ganetzky B, et al: HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995;269:92-95.
23. Shah RR: Drug-induced QT interval prolongation - regulatory guidance and perspectives on hERG channel studies. Novartis Found Symp 2005;266:251-280.
24. + channels expressed in mammalian cell lines and Xenopus oocytes. J Pharmacol Toxicol Methods 2002;48:65-80.
25. Yang T, Roden DM: Extracellular potassium modulation of drug block of IKr: Implications for torsades de pointes and reverse usedependence. Circulation 1996;93:407-411.
26. Busch AE, Eigenberger B, Jurkiewicz NK, Salata JJ, Pica A, Suessbrich H, Lang F: Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. Br J Pharmacol 1998;123:23-30.
27. Duff HJ, Feng ZP, Fiset C, Wang L, Lees-Miller J, Sheldon RS: [3H]dofetilide binding to cardiac myocytes: modulation by extracellular potassium. J Mol Cell Cardiol 1997;29:183-191.
28. Lin C, Cvetanovic I, Ke X, Ranade V, Somberg J: A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther 2005;12:328-336.
29. Lin C, Ke X, Cvetanovic I, Ranade V, Somberg J: The influence of extracellular acidosis on the effect of IKr blockers. J Cardiovasc Pharmacol Ther 2005;10:67-76.